GlaxoSmithKline Pharmaceuticals on Monday said it has made a foray into the oncology segment, bringing precision therapies ...

GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

GlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological ...

GSK enters oncology with Jemperli & Zejula for gynaecological cancers in India. Advanced therapies address unmet needs in ...

Jemperli is the first and only approved programmed death receptor-1 (PD-1) immunotherapy for the second-line treatment of ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated in the future ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- ...

Loni Anderson's cause of death was metastatic uterine leiomyosarcoma, a rare and aggressive form of cancer. She passed away ...

GlaxoSmithKline (GSK) has entered India's oncology sector with the launch of Jemperli and Zejula. These therapies address the increasing need for specialized cancer treatments.

Karen Thursby, a Darlington -based yoga teacher who lost her mother Lola to bile duct cancer in 2017, has been organising ...